247 assets in Acute Lymphoblastic Leukemia

Therapeutic assets addressing Acute Lymphoblastic Leukemia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Mesna Acute Lymphoblastic Leukemia	Center for International Blood and Marrow Transplant Research	P2	B (62)
Ruxolitinib Acute Lymphoblastic Leukemia	Bambino Gesù Hospital and Research Institute	P2/3	B (62)
Allogeneic Human Umbilical Cord Blood Acute Lymphoblastic Leukemia	Leland Metheny	P2	B (61)
Bendamustine Acute Lymphoblastic Leukemia	St. Petersburg State Pavlov Medical University	P2	B (61)
Clofarabine Acute Lymphoblastic Leukemia	Memorial Sloan Kettering Cancer Center	P3	B (60)
Cnct19 Acute Lymphoblastic Leukemia	Juventas Cell Therapy Ltd.	P2	B (60)
Hpc, Cord Blood Acute Lymphoblastic Leukemia	Memorial Sloan Kettering Cancer Center	P2	B (60)
Irinotecan Acute Lymphoblastic Leukemia	Tanja Andrea Gruber	P2/3	B (60)
Ponatinib Acute Lymphoblastic Leukemia	University of Alberta	P2/3	B (60)
Treosulfan Acute Lymphoblastic Leukemia	Federal Research Institute of Pediatric Hematology, Oncology and Immunology	P2/3	B (60)
Venetoclax Acute Lymphoblastic Leukemia	Princess Maxima Center for Pediatric Oncology	P3	B (60)
Azacitidine Acute Lymphoblastic Leukemia	The First Affiliated Hospital of Soochow University	P2	B (58)
Cart-19 And 20 Cells Acute Lymphoblastic Leukemia	University of Sao Paulo	P2/3	B (58)
Cladribine Acute Lymphoblastic Leukemia	The First Affiliated Hospital of Soochow University	P2/3	B (58)
Nelarabine Acute Lymphoblastic Leukemia	Emory University	P3	B (58)
Vitamin D Acute Lymphoblastic Leukemia	St. Petersburg State Pavlov Medical University	P3	B (58)
Diphenhydramine Acute Lymphoblastic Leukemia	PersonGen BioTherapeutics (Suzhou) Co., Ltd.	P2	B (57)
Ibrutinib Acute Lymphoblastic Leukemia	Novartis Pharmaceuticals	P2	B (57)
Murine Autologous Anti-Cd19 Chimeric Antigen Receptor T Cells Acute Lymphoblastic Leukemia	Beijing Boren Hospital	P2	B (57)
Nivolumab Acute Lymphoblastic Leukemia	Assistance Publique - Hôpitaux de Paris	P1/2	B (57)
Palbociclib Acute Lymphoblastic Leukemia	Tanja Andrea Gruber	P1/2	B (57)
cd22 car-transduced t cells Acute Lymphoblastic Leukemia	National Cancer Institute (NCI)	P2	B (56)
L-Ofloxacin Acute Lymphoblastic Leukemia	Gadjah Mada University	P4	B (56)
Olverembatinib Acute Lymphoblastic Leukemia	M.D. Anderson Cancer Center	P3	B (56)
Revumenib Acute Lymphoblastic Leukemia	M.D. Anderson Cancer Center	P2	B (56)
Simvastatin Acute Lymphoblastic Leukemia	Hospital General de Mexico	P4	B (56)
Ursodeoxycholic Acid Acute Lymphoblastic Leukemia	Ain Shams University	P4	B (56)
Vorinostat Acute Lymphoblastic Leukemia	Tanja Andrea Gruber	P2/3	B (56)
Ceftazidime Acute Lymphoblastic Leukemia	Gadjah Mada University	P4	CCC (54)
Ciprofloxacin Acute Lymphoblastic Leukemia	Gadjah Mada University	P4	CCC (54)
Dexrazoxane Acute Lymphoblastic Leukemia	Andrew E. Place, MD	P3	CCC (54)
Everolimus Acute Lymphoblastic Leukemia	OHSU Knight Cancer Institute	P1/2	CCC (54)
Inotuzumab Acute Lymphoblastic Leukemia	St. Jude Children's Research Hospital	P3	CCC (54)
Isatuximab Acute Lymphoblastic Leukemia	Assistance Publique - Hôpitaux de Paris	P2/3	CCC (54)
Multi-Peptide Cmv-Modified Vaccinia Ankara Vaccine Acute Lymphoblastic Leukemia	City of Hope Medical Center	P2	CCC (54)
Pegfilgrastim Acute Lymphoblastic Leukemia	M.D. Anderson Cancer Center	P2	CCC (54)
Anti-Cd19 Car T-Cells Acute Lymphoblastic Leukemia	KK Women's and Children's Hospital	P2	CCC (53)
Ari-0001 Acute Lymphoblastic Leukemia	Sara V. Latorre	P2	CCC (53)
Auto Car T Cell Therapy Acute Lymphoblastic Leukemia	Autolus Limited	P2	CCC (53)
cd19-cart Acute Lymphoblastic Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P2	CCC (53)
cd19+cd22 car-t Acute Lymphoblastic Leukemia	The First Affiliated Hospital of Soochow University	P2	CCC (53)
cd45ra-depleted dli Acute Lymphoblastic Leukemia	St. Jude Children's Research Hospital	P2	CCC (53)
Mgta-456 Acute Lymphoblastic Leukemia	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Nadravaleucel Acute Lymphoblastic Leukemia	David Wald	P1/2	CCC (53)
Ptcy Acute Lymphoblastic Leukemia	Center for International Blood and Marrow Transplant Research	P2	CCC (53)
Pyronaridine Tetraphosphate Acute Lymphoblastic Leukemia	Armaceutica, Inc.	P2	CCC (53)
Sscart-19 Acute Lymphoblastic Leukemia	Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd	P2	CCC (53)
Vedolizumab Acute Lymphoblastic Leukemia	City of Hope Medical Center	P3	CCC (53)
Decitabine Acute Lymphoblastic Leukemia	Princess Maxima Center for Pediatric Oncology	P1/2	CCC (52)
hem101 Acute Lymphoblastic Leukemia	National Research Center for Hematology, Russia	P1/2	CCC (52)

Showing 51 to 100 of 247 assets

PreviousPage 2 of 5Next